Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Benzydamine/econazole - Angelini Pharmaceuticals

Next Previous
Drug Profile

Benzydamine/econazole - Angelini Pharmaceuticals

Alternative Names: Benzydamine HCl and econazole nitrate - Angelini Pharmaceuticals; Benzydamine HCl/econazole nitrate - Angelini Pharmaceuticals

Latest Information Update: 10 Feb 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Angelini Pharmaceuticals
  • Class Antifungals; Azoles; Dimethylamines; Fenamates; Imidazoles; Indazoles; Nonsteroidal anti-inflammatories; Propanolamines; Small molecules
  • Mechanism of Action 14-alpha demethylase inhibitors; Cyclooxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Vulvovaginal candidiasis

Most Recent Events

  • 10 Feb 2026 Discontinued - Phase-III for Vulvovaginal candidiasis (In the elderly, In adults) in Italy, Bulgaria, Poland (Vaginal)
  • 25 Feb 2022 Benzydamine/econazole is still in phase III trials for Vulvovaginal candidiasis (In adults, In the elderly) in Bulgaria, Poland, Italy (Vaginal)
  • 27 Mar 2018 Chemical structure information added

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top